Marin Abraham, Dominic Augustine, Roopa S Rao, S V Sowmya, Vanishri C Haragannavar, Shwetha Nambiar, Kavitha Prasad, Kamran Habib Awan, Shankargouda Patil
{"title":"天然提取物抑制癌症进展:一项系统综述。","authors":"Marin Abraham, Dominic Augustine, Roopa S Rao, S V Sowmya, Vanishri C Haragannavar, Shwetha Nambiar, Kavitha Prasad, Kamran Habib Awan, Shankargouda Patil","doi":"10.1177/2156587217744914","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This systematic review is aimed at evaluating the literature on the efficacy of naturally available extracts that inhibit cancer.</p><p><strong>Methods: </strong>A literature search was performed to strengthening the reporting of observational studies in epidemiology analysis. Approximately 3000 research articles were initially selected. Of these articles, 200 were included, and 2800 were excluded. On further scrutiny, 150 of the 200 studies were reviews, seminars, and presentations, and 50 were original study articles. Among these articles, 20 studies were selected for the systematic review.</p><p><strong>Results: </strong>The predominant molecular pathways followed by natural extracts were nuclear factor kappa B ligand, suppression of the protein kinase B-Akt/P13K pathway (an intracellular signaling pathway important in regulating cell cycle), vascular endothelial growth factor downregulation, and tumor protein-P53 tumor suppressor upregulation.</p><p><strong>Conclusions: </strong>It is evident that natural extracts have the ability to inhibit cancer progression. Continued research in this field could facilitate the use of natural extracts with currently available anticancer agents.</p>","PeriodicalId":15804,"journal":{"name":"Journal of Evidence-Based Complementary & Alternative Medicine","volume":"22 4","pages":"870-878"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2156587217744914","citationCount":"9","resultStr":"{\"title\":\"Naturally Available Extracts Inhibiting Cancer Progression: A Systematic Review.\",\"authors\":\"Marin Abraham, Dominic Augustine, Roopa S Rao, S V Sowmya, Vanishri C Haragannavar, Shwetha Nambiar, Kavitha Prasad, Kamran Habib Awan, Shankargouda Patil\",\"doi\":\"10.1177/2156587217744914\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>This systematic review is aimed at evaluating the literature on the efficacy of naturally available extracts that inhibit cancer.</p><p><strong>Methods: </strong>A literature search was performed to strengthening the reporting of observational studies in epidemiology analysis. Approximately 3000 research articles were initially selected. Of these articles, 200 were included, and 2800 were excluded. On further scrutiny, 150 of the 200 studies were reviews, seminars, and presentations, and 50 were original study articles. Among these articles, 20 studies were selected for the systematic review.</p><p><strong>Results: </strong>The predominant molecular pathways followed by natural extracts were nuclear factor kappa B ligand, suppression of the protein kinase B-Akt/P13K pathway (an intracellular signaling pathway important in regulating cell cycle), vascular endothelial growth factor downregulation, and tumor protein-P53 tumor suppressor upregulation.</p><p><strong>Conclusions: </strong>It is evident that natural extracts have the ability to inhibit cancer progression. Continued research in this field could facilitate the use of natural extracts with currently available anticancer agents.</p>\",\"PeriodicalId\":15804,\"journal\":{\"name\":\"Journal of Evidence-Based Complementary & Alternative Medicine\",\"volume\":\"22 4\",\"pages\":\"870-878\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/2156587217744914\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Evidence-Based Complementary & Alternative Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/2156587217744914\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/12/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Evidence-Based Complementary & Alternative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2156587217744914","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/12/11 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Naturally Available Extracts Inhibiting Cancer Progression: A Systematic Review.
Aim: This systematic review is aimed at evaluating the literature on the efficacy of naturally available extracts that inhibit cancer.
Methods: A literature search was performed to strengthening the reporting of observational studies in epidemiology analysis. Approximately 3000 research articles were initially selected. Of these articles, 200 were included, and 2800 were excluded. On further scrutiny, 150 of the 200 studies were reviews, seminars, and presentations, and 50 were original study articles. Among these articles, 20 studies were selected for the systematic review.
Results: The predominant molecular pathways followed by natural extracts were nuclear factor kappa B ligand, suppression of the protein kinase B-Akt/P13K pathway (an intracellular signaling pathway important in regulating cell cycle), vascular endothelial growth factor downregulation, and tumor protein-P53 tumor suppressor upregulation.
Conclusions: It is evident that natural extracts have the ability to inhibit cancer progression. Continued research in this field could facilitate the use of natural extracts with currently available anticancer agents.
期刊介绍：
The Journal of Evidence-Based Integrative Medicine ((JEBIM)), published previously as the Journal of Evidence-Based Complementary and Alternative Medicine (JEBCAM) and also as Complementary Health Practice Review (CHPR). The Journal of Evidence-Based Integrative Medicine (JEBIM) is an interdisciplinary, peer-reviewed, open access, biomedical journal whose aim is to create a global platform for hypothesis-driven and evidence-based research in all fields of integrative medicine. The journal’s objective is to publish papers which impart scientific validity to Integrative Medicine methods that are indispensable and inevitable in today’s world. All papers will be peer reviewed by experts in their respective fields, and papers will be accepted based on their scientific merit. It is the goal of the Journal to help remove the “myth” and provide scientific rationale for the various methodologies and theories of Integrative Medicine. All submissions will be reviewed based on their scientific merit and only papers with sound study design, valid statistical analyses and logical conclusions will be accepted. Topics include, but are not limited to: Traditional Eastern and Western medicine Nutrition therapy and supplementation Massage Therapy Non-traditional treatments Preventative medicine Integrative health and medicine Mindfulness Yoga.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
